The overall survival data from GEPIA2 demonstrated that low levels of FAU, RPS17, and RPS 24 were significantly associated with shorter survival, while high CCL4 was significantly associated with shorter survival in thymoma patients. This evidence concerns the gene CCL4 and thymoma.